TGFB1 and colorectal cancer: Foundational work in urothelial and colorectal cancer showed that TGF-β–dependent stromal activation confines effector T cells to peritumoral territories and that dual blockade of TGF-β and PD-(L)1 can restore intratumoral T-cell access (12–15).